• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靛玉红-3'-单肟,一种中国抗白血病药物的衍生物,可抑制Notch1信号通路。

Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.

作者信息

Lee Mi-Jee, Kim Mi-Yeon, Mo Jung-Soon, Ann Eun-Jung, Seo Mi-Sun, Hong Ji-Ae, Kim Yong-Chul, Park Hee-Sae

机构信息

Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Yongbong-dong, Gwangju, Republic of Korea.

出版信息

Cancer Lett. 2008 Jul 8;265(2):215-25. doi: 10.1016/j.canlet.2008.02.013. Epub 2008 Mar 17.

DOI:10.1016/j.canlet.2008.02.013
PMID:18343569
Abstract

Notch proteins perform a critical function in cell-fate decisions and in differentiation. In this study, we determined that indirubin-3'-monoxime reduced Notch1 signaling to a remarkable extent. Indirubin-3'-monoxime has been shown to inhibit both constitutive active mutants of Notch1 and Notch1-IC-mediated transactivation activity. However, in such cases, neither the Notch cleavage pattern nor the protein stability of Notch1-IC was determined to have been significantly altered. Indirubin-3'-monoxime suppresses Notch1 transcriptional activity via the dissociation of the Notch1-IC-RBP-Jk complex. Notably, the transcriptional activity of Notch1-IC was not suppressed significantly in the GSK-3beta null cells by indirubin-3'-monoxime as compared to what was observed with GSK-3beta wild-type cells. In the previous study, we synthesized a series of indirubin derivatives. Interestingly, some of these indirubin derivatives were characterized as potent inhibitors of Notch1 signaling. Taken together, the results of this study indicate that indirubin-3'-monoxime downregulated Notch1 signaling in a GSK-3beta-dependent and proteosomal degradation-independent manner.

摘要

Notch蛋白在细胞命运决定和分化过程中发挥着关键作用。在本研究中,我们确定靛玉红-3'-单肟能显著降低Notch1信号传导。靛玉红-3'-单肟已被证明可抑制Notch1的组成型活性突变体以及Notch1-IC介导的反式激活活性。然而,在这些情况下,未确定Notch的切割模式或Notch1-IC的蛋白质稳定性有显著改变。靛玉红-3'-单肟通过Notch1-IC-RBP-Jk复合物的解离来抑制Notch1转录活性。值得注意的是,与GSK-3β野生型细胞相比,靛玉红-3'-单肟在GSK-3β缺失细胞中对Notch1-IC转录活性的抑制作用并不显著。在先前的研究中,我们合成了一系列靛玉红衍生物。有趣的是,其中一些靛玉红衍生物被鉴定为Notch1信号的有效抑制剂。综上所述,本研究结果表明靛玉红-3'-单肟以GSK-3β依赖性和蛋白酶体降解非依赖性方式下调Notch1信号传导。

相似文献

1
Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.靛玉红-3'-单肟,一种中国抗白血病药物的衍生物,可抑制Notch1信号通路。
Cancer Lett. 2008 Jul 8;265(2):215-25. doi: 10.1016/j.canlet.2008.02.013. Epub 2008 Mar 17.
2
Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.靛玉红-3'-单肟抑制FGFR1的自磷酸化,并通过p38丝裂原活化蛋白激酶刺激ERK1/2活性。
Oncogene. 2007 Sep 27;26(44):6372-85. doi: 10.1038/sj.onc.1210473. Epub 2007 May 28.
3
Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.靛玉红-3'-单肟,一种CDK抑制剂,可诱导移行细胞癌中生长抑制及不依赖凋亡的生存素上调。
Anticancer Res. 2006 May-Jun;26(3A):2129-35.
4
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.靛玉红-3'-单肟(一种细胞周期蛋白依赖性激酶/糖原合成酶激酶-3抑制剂)的抗有丝分裂特性:前期停滞诱导核内复制。
Oncogene. 2001 Jun 28;20(29):3786-97. doi: 10.1038/sj.onc.1204503.
5
Downregulation by lipopolysaccharide of Notch signaling, via nitric oxide.脂多糖通过一氧化氮对Notch信号通路的下调作用。
J Cell Sci. 2008 May 1;121(Pt 9):1466-76. doi: 10.1242/jcs.019018. Epub 2008 Apr 14.
6
Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.Bid和Bax在靛玉红-3'-单肟诱导人癌细胞凋亡中的关键作用。
Biochem Pharmacol. 2008 May 1;75(9):1729-42. doi: 10.1016/j.bcp.2008.01.021. Epub 2008 Mar 10.
7
6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.6-Br-5 甲基靛红-3'肟(5-Me-6-BIO)靶向利什曼原虫糖原合酶激酶-3(GSK-3)短形式,影响细胞周期进程并诱导类似凋亡的死亡:利用 GSK-3 治疗利什曼病。
Int J Parasitol. 2009 Oct;39(12):1289-303. doi: 10.1016/j.ijpara.2009.04.005. Epub 2009 May 13.
8
Regulation of Notch1 signaling by the APP intracellular domain facilitates degradation of the Notch1 intracellular domain and RBP-Jk.APP 细胞内结构域对 Notch1 信号的调控有助于 Notch1 细胞内结构域和 RBP-Jk 的降解。
J Cell Sci. 2011 Jun 1;124(Pt 11):1831-43. doi: 10.1242/jcs.076117. Epub 2011 May 10.
9
Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells.靛玉红-3'-单肟对肾癌细胞的抗增殖和诱导凋亡作用。
Urol Oncol. 2011 Nov-Dec;29(6):815-20. doi: 10.1016/j.urolonc.2009.10.005. Epub 2009 Nov 27.
10
Zinc-induced downregulation of Notch signaling is associated with cytoplasmic retention of Notch1-IC and RBP-Jk via PI3k-Akt signaling pathway.锌诱导的Notch信号下调与Notch1-IC和RBP-Jk通过PI3k-Akt信号通路在细胞质中的滞留有关。
Cancer Lett. 2007 Sep 18;255(1):117-26. doi: 10.1016/j.canlet.2007.04.002. Epub 2007 May 21.

引用本文的文献

1
Revisiting the Role of GSK3, A Modulator of Innate Immunity, in Idiopathic Inclusion Body Myositis.重新审视 GSK3 在特发性包涵体肌炎中的作用,GSK3 是先天免疫的调节剂。
Cells. 2021 Nov 21;10(11):3255. doi: 10.3390/cells10113255.
2
Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins.小分子在鳞状细胞癌治疗中的应用:聚焦靛玉红
Cancers (Basel). 2021 Apr 7;13(8):1770. doi: 10.3390/cancers13081770.
3
Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges.
靶向癌症中的STAT-3信号通路以开发新型药物:进展与挑战。
Genet Mol Biol. 2020 Feb 10;43(1):e20180160. doi: 10.1590/1678-4685-GMB-2018-0160. eCollection 2020.
4
Nutritional Preconditioning of Apigenin Alleviates Myocardial Ischemia/Reperfusion Injury via the Mitochondrial Pathway Mediated by Notch1/Hes1.芹菜素的营养预处理通过 Notch1/Hes1 介导的线粒体途径减轻心肌缺血/再灌注损伤。
Oxid Med Cell Longev. 2019 Mar 20;2019:7973098. doi: 10.1155/2019/7973098. eCollection 2019.
5
Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations.系统药理学筛选揭示了参与脑动静脉畸形的新途径。
EMBO Mol Med. 2018 Oct;10(10). doi: 10.15252/emmm.201809155.
6
Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression.靛玉红和异吲哚酮对细胞活力、致突变性、遗传毒性及BAX/ERCC1基因表达的影响。
Pharm Biol. 2017 Dec;55(1):2005-2014. doi: 10.1080/13880209.2017.1354387.
7
Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds.新型吲哚啉-2-酮作为强效抗癌化合物的设计、合成及生物学评价
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3326-3331. doi: 10.1016/j.bmcl.2017.06.019. Epub 2017 Jun 7.
8
Indirubin Treatment of Lipopolysaccharide-Induced Mastitis in a Mouse Model and Activity in Mouse Mammary Epithelial Cells.靛玉红对小鼠模型中脂多糖诱导的乳腺炎的治疗作用及对小鼠乳腺上皮细胞的活性影响
Mediators Inflamm. 2017;2017:3082805. doi: 10.1155/2017/3082805. Epub 2017 Feb 1.
9
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.用于对抗增殖性疾病的靛玉红及靛玉红衍生物
Evid Based Complement Alternat Med. 2015;2015:654098. doi: 10.1155/2015/654098. Epub 2015 Sep 17.
10
Targeting STAT3 in cancer: how successful are we?在癌症中靶向 STAT3:我们有多成功?
Expert Opin Investig Drugs. 2009 Jan;18(1):45-56. doi: 10.1517/13543780802565791.